Artrya Ltd Sustainability Reports
Artrya Limited is a medical technology company that develops and commercializes artificial intelligence software solutions to assist clinicians in the detection and management of coronary artery disease. Its proprietary Salix platform analyzes coronary CT angiography scans to identify key biomarkers of heart disease.
Sector: Technology & telecommunications
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG010QF6857
2 reports from 2022 to 2023
